Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Scheinberg P et al. - Despite a theoretical rationale for its use, sirolimus did not improve the response rate in patients with severe aplastic anemia when compared to standard h-ATG/CsA

Related Articles

Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09    Relevance Score: 69%

Aplastic anemia in the orient
International Journal of Hematology, 10/07/09    Relevance Score: 67%

New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09    Relevance Score: 67%

The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09    Relevance Score: 67%

Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
Pediatric Hematology and Oncology, 10/02/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address